China-rooted AI biotech Earendil Labs raises $787M ahead of possible IPOnews2026-03-20T15:16:10+00:00March 20th, 2026|Endpoints News|
UK’s NICE revisits Lilly, Eisai Alzheimer’s drugs under new pricing thresholdnews2026-03-20T14:51:59+00:00March 20th, 2026|Endpoints News|
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Developmentnews2026-03-20T12:03:17+00:00March 20th, 2026|Medical Device News Magazine|
Novo Holdings CEO discusses investments, geopolitics and Chinanews2026-03-20T12:00:34+00:00March 20th, 2026|Endpoints News|
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovationnews2026-03-20T11:40:21+00:00March 20th, 2026|Endpoints News|
Idorsia looks for another CEO — again; Former Jazz exec makes a comebacknews2026-03-20T11:00:00+00:00March 20th, 2026|Endpoints News|
